seed
Stage
2
Investors
About
Bioherent develops advanced photonic biosensor technologies using silicon photonics and nanomaterials to provide fast, accurate, and accessible in vitro diagnostic tools focused on antibiotic and acute drug allergy detection.
Explore Bioherent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.